-
Product Insights
Anal Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Anal Cancer - Drugs In Development, 2023’, provides an overview of the Anal Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Anal Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Rectal Cancer – Drugs In Development, 2023
Global Markets Direct’s, ‘Rectal Cancer - Drugs In Development, 2023’, provides an overview of the Rectal Cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development for Rectal Cancer, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Colon Carcinoma – Drugs In Development, 2023
Global Markets Direct’s, ‘Colon Carcinoma - Drugs In Development, 2023’, provides an overview of the Colon Carcinoma pipeline landscape. The report provides comprehensive information on the therapeutics under development for Colon Carcinoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Colorectal Tumor – Drugs In Development, 2023
Global Markets Direct’s, ‘Colorectal Tumor - Drugs In Development, 2023’, provides an overview of the Colorectal Tumor pipeline landscape. The report provides comprehensive information on the therapeutics under development for Colorectal Tumor, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Sector Analysis
Colorectal Cancer in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2031
Colorectal Cancer Market Report Overview The colorectal cancer market sales across the 8MM were estimated at $15.8 billion in 2021. The market is expected to achieve a CAGR of more than 3% during 2021-2031. The global growth is driven by the anticipated approval and launch of 14 pipeline therapies and the label expansions of other agents. Colorectal cancer Market Outlook, 2021-2031 ($ Billion) Buy the Full Report to Know More about the Colorectal cancer Market Forecast Download A Free Report...
-
Sector Analysis
Anal Cancer (AC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Anal Cancer Marketed and Pipeline Drugs Report Overview Anal cancer develops in the cells and tissue of the skin lining on either the inside or outside of the anus. The development of anal cancer is directly linked to a complex inflammatory process secondary to infections such as (HPV) types 16 and 18. The progression of this inflammatory process heralds the development of anal intraepithelial neoplasia (AIN), or squamous cell carcinoma (SCC) in situ (Bowen disease), which is a pre-malignant condition....
-
Thematic Analysis
Digital Marketing Trends in Colorectal Cancer
Digital Marketing Trends in Colorectal Cancer Report Overview Merck’s Keytruda.com achieved the highest total traffic across colorectal cancer (CRC) patient sites in the US. This was followed by Bristol Myers Squibb’s (BMS’s) Opdivo.com and Roche’s Avastin.com. Overall, the highest proportion of traffic to top branded patient CRC websites originated from direct sources, followed by organic sources. The Digital Marketing Trends in the Colorectal Cancer research report assesses key digital marketing metrics of pharma assets in CRC, including branded websites for patients...
-
Product Insights
Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Colorectal Cancer Pipeline Drugs Market Overview Colorectal cancer starts in the colon or the rectum. It begins as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools, and weight loss with no known reasons. Risk factors for colorectal cancer include smoking, heavy alcohol use, inflammatory bowel disease (IBD), and family history. Treatment includes...
-
Sector Analysis
Colorectal Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast, 2031
Colorectal Cancer Market Report Overview The Colorectal Cancer (CRC) 15 (CGT and established/conventional therapies) market size was $18.9 billion in 2021. CRC has one of the largest gene therapy/oncolytic virus clinical pipelines across all of oncology, and a relatively active clinical cell therapy pipeline compared to other solid tumors. There are currently no marketed or Phase III CGT agents in CRC, reflecting the difficulties of progressing these drug types into the CRC market. This is largely due to insufficient efficacy; however, there...
-
Sector Analysis
Colorectal Cancer Epidemiology Analysis and Forecast, 2021-2031
Colorectal Cancer Epidemiology Analysis Overview The total number of cases affected by colorectal cancer was 3,183,569 in 2021. The number of cases is expected to grow at an AGR of more than 3% during the forecast period. Colorectal cancer, also referred as bowel cancer, is the cancer of the colon, rectum, or rectosigmoid junction. It is a type of gastrointestinal malignancy originating from either the colon or the rectum. Although both forms can be defined as colon or rectal cancers,...